 Dupont Capital Management Corp cut its holdings in shares of Akebia Therapeutics Inc NASDAQ:AKBA by 8.2 in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission SEC. The institutional investor owned 34,238 shares of the biopharmaceutical companys stock after selling 3,057 shares during the period. Dupont Capital Management Corps ... 